How pharmaceutical companies train their workers on artificial intelligence

• Pharmaceutical giants such as J & J, Merck and Eli Lilly embrace artificial intelligence and give priority.

• They hope that the training of thousands of employees in the productive obstetric intelligence will enhance the development of medicines.

• This article is part of “AI In Action”, a series that explores how companies implement artificial intelligence innovations.

Johnson & Johnson adopts the concept of a two -language employee – but not in the classic sense.

For the pharmaceutical company, literacy is needed in specialized and basic job skills, including research, supply and financing chain. Then there is fluency in artificial intelligence technology.

“There are many ways that we have used by Amnesty International,” said Jim Swanson, the chief information official at J & J. “But to do this effectively, we really had to create a curriculum and mental about Upskengling.”

More than 56,000 J & J agents took 138,000 training workers from artificial intelligence, which is required before any employee is allowed to use technology. After training, J & J staff can take advantage of the Truc Motory Intelligence tools to summarize and rapid engineering, and the last skill to ask the correct question to get the best output of a large language model. A separate, deeper digital boot camp, including artificial intelligence, augmented reality and automation, recorded more than 37,000 cumulative hours of training from more than 14,000 employees.

AI Al -Tulaidi provides a promise to identify new vehicles and vaccines more quickly for new treatments and vaccines, accelerate the development of medicines, simplifying organizational compliance, improving the most suitable patients for clinical trials, and improving how to market new drugs.

Deborah Golden, the American chief innovation employee in Deloitte, said this progress was ready to change the skills that the pharmaceutical industry gives priority in employment. Knowing biology and chemistry will remain, but it is not necessary for the latest roles such as artificial intelligence engineers, and other new roles may require a mixture of traditional experience and knowledge of artificial intelligence if the detection of drugs moved by artificial intelligence is spreading.

“When you think about how artificial intelligence turns into balance and talent requirements, you really need to be able to speak biology and artificial intelligence models,” said Golden.

Tummy artificial intelligence can save dozens of pharmaceutical industry from billions of dollars every year by improving productivity in the development of medicines.

J & J, the therapy maker such as immunosuppressive drug and Darzalex, which is a drug to treat multiple myeloma, has used more traditional forms of artificial intelligence for nearly a decade. User cases include software tools that are enabled from artificial intelligence that can direct the surgeon through procedure, accelerate the detection of drugs, and help drug makers manage stockpiles more effectively.

In 2023, J & J tried a six -week digital immersion program that focuses on AI, data science and other emerging technologies. More than 2,500 employees participated last year, where they got 90 minutes every week, and J & J plans for more expansion this year.

Business Insider told the company’s leaders to create a culture that enhances technological literacy. “We have gone through about 135 years. We have had to re -invent ourselves several times to stay in connection and modern,” he said.

The AI’s early AI’s giant investments included in Merck Merck the development of a royal platform called GPTEAL. Merck – who is responsible for the HPV and Keytruda immunotherapy – said that GPTEAL allows employees access to large language models such as Chatgpt from Openai, Meta’s Llama and Claude’s HotHropic while maintaining the company’s safe data from external sites.

Employees also use Amnesty International to formulate emails, notes and other productivity tasks, but Merck’s aspirations are also bolder.

“Now, it is clear that the journey is to identify, track and measure the cases of use that have a significant impact on our business,” said Ron Kim, Senior Vice President of Merck.

AI Tolidi allows MERCK employees more time to focus on high -impact tasks. In the discovery of drugs, for example, the artificial intelligence can help with the formulation of organizational documents (which the human being reviewed) that are submitted to the health authorities. Kim said: “We felt that some of our scholars were taking time to copy.” “This is not what they trained.”

Kim said more than 50,000 Merck employees used GPTEAL regularly. The company has supported compensation through a mixture of digital training courses, the monthly network broadcasting focused on obstetric artificial intelligence, and preparation camps for software developers that can continue anywhere from half a day to 10 days.

Dr. Daniel Stevens, chief medical official at Blue Earth Therapeutics, said that artificial intelligence was attractive to the radiological pharmaceutical company in the clinical stage because, as, as a small startup established in 2021, it should be wise in how to spend the capital.

“The application of artificial intelligence is important, because it may help us in some of our efficiency goals,” said Stevens.

The 76.5 million dollar chain in October, which included financing from Soleus Capital Soleus Capital and the Diagnostic Photography Company, mostly aimed at supporting clinical trials that will evaluate the safety and effectiveness of new prostate cancer treatments.

Stevens said that with only 20 full -time employees, Blue Earth did not need to provide AI Upskill training. He added that when Blue Earth grows its employee base and is ready to provide instructions on technology, it plans to use online training courses and artificial intelligence certificates from external sellers.

Use Eli Lilly, the drug giant behind treatments including anti -depressant Prozac, type 2 diabetes and Mountaro weight loss medicine, artificial intelligence to support the search for both small and large molecules. The company also used artificial intelligence to generate clinical trial documents and create organizational submission materials.

After the launch of ChatGPT, the main employers such as Apple and Amazon restricted employees’ use for famous Chatbot, with many concerns about data privacy. “We have gone in the exact opposite direction,” said Dugo Rao, chief official in Information and digital number at Elie Lily.

RAU encouraged Eli Lilly’s workforce to adopt the tool without exposing the company’s sensitive information, similar to how the employee can use Google search.

“Everyone told us that you need to use it,” Rao said. “You need to start bringing Chatgpt to your work.” But he added: “Don’t put anything there you don’t want to go out.”

The company also internally sought to enhance interest in the “Artificial Intelligence Games” in the summer Olympics in Paris. Competitions included using Chatbot to write a message to a colleague or rely on obstetric artificial intelligence for a test on Elie Lily’s history.

In 2024, Eli Lilly also encouraged all employees and managers to use obstetric intelligence for reviews at the end of the year. This year, the company is scheduled to require all leaders and managers to obtain an artificial intelligence certificate.

“We have a workforce that adopts artificial intelligence,” Rao said, adding that the employees often stopped him in the office or sent it by email to share the roads that Amnesty International was applying to daily work tasks.

Read the original article on Business Insider